Coronavirus (COVID-19) FAQs
IOP Publishing acknowledges the devastating impact Coronavirus (COVID-19) is having around the world. Ensuring a safe environment for our employees and customers is our key focus, while minimising disruptions to allow our services to continue. This outlines the measures we have taken – these will be adjusted as necessary as we regularly assess developments.
What precautions are you taking for staff in areas of the world affected by Coronavirus?
The wellbeing and safety of everyone remains our priority. To minimise the risk to staff, our employees are successfully working remotely. We will continue to monitor the situation closely and proactively follow healthcare and government advice.
Will Covid-19 impact your ability to deliver services to customers?
We have established continuity plans in place to effectively manage situations like this. To date, our business has continued uninterrupted worldwide and we do not expect this to change. Access to all of our systems remains unaffected, including access to our content hosting platform IOPscience.
Are you offering extensions to researchers in affected areas?
Yes. We are offering extensions for any researchers whose ability to work is affected by the Coronavirus outbreak. We understand that many may find it difficult to meet journal deadlines and encourage anyone who needs an extension to contact their relevant journal team or email@example.com with their manuscript number.
Are you enabling access to content for students and researchers who are unable to make it to campus?
Yes. In China, we have partnered with the CARSI Federation to enable researchers and students in China remote access to IOPscience without the need for campus IP addresses or VPNs. For more information, please visit the guidance page on our dedicated IOPP China site.
For other regions, we will work with any customers who may need it to enable remote access to IOPscience. We have also taken steps to ensure our systems are ready to manage any increase in web traffic that may result from online-only working. For guidance on how to access IOPscience off-campus, please see these instructions.
Will you be extending renewal periods for journal subscriptions?
To ensure uninterrupted access, on a case by case basis we will be extending renewal periods for subscribers.
Will I still receive print copies of journals?
We are currently able to continue with our journal subscription print production and distribution, although we have switched from air to sea freight for bulk dispatch to the US, which will take a little longer to arrive. However, many countries are now experiencing difficulties and are restricting the onward delivery of the print copies: specific postal updates can be found on our distributors’ website https://www.airbusiness.com/service-update. We will continue to assess the situation on a weekly basis. In the meantime, you would like to pause the delivery of your print journals, please contact firstname.lastname@example.org.
Are you making COVID-19 research you publish freely available?
Yes. Any relevant published or forthcoming articles will be made immediately available to PubMed Central throughout the duration of the crisis, with rights to enable text and data mining, re-use and secondary analysis. We will do whatever we can to assist researchers, medical professionals, policy makers and others who are working to address this public health emergency. A full list of these articles is below, ordered chronologically.
- Electron Beam Irradiation on Novel Coronavirus (COVID-19): via a Monte-Carlo Simulation
- Main trends in the design of semi-synthetic antibiotics of a new generation
- Microbial volatile compounds in health and disease conditions
- The study of parasite sharing for surveillance of zoonotic diseases
- Modelling of potentially promising SARS protease inhibitors
- Detection of feline coronavirus using microcantilever sensors
- Volatile fingerprinting of human respiratory viruses from cell cultures
- The effect of RNA stiffness on the self-assembly of virus particles
- Multi-scale problem in the model of RNA virus evolution
- Review—Chemical and Biological Sensors for Viral Detection
- Droplet Microfluidic Chip Based Nucleic Acid Amplification and Real-Time Detection of Influenza Viruses
- Detection of Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein Using AlGaN/GaN High Electron Mobility Transistors
- Use of an innovative and non-invasive device for virologic sampling of cough aerosols in patients with community and hospital acquired pneumonia: a pilot study
- Investigating the thermal dissociation of viral capsid by lattice model
- Self-assembly of model proteins into virus capsids
- Length of encapsidated cargo impacts stability and structure of in vitro assembled alphavirus core-like particles
- Assembly/disassembly of a complex icosahedral virus to incorporate heterologous nucleic acids
- Membrane vesiculation induced by proteins of the dengue virus envelope studied by molecular dynamics simulations
- Varieties of charge distributions in coat proteins of ssRNA+ viruses
- TensorCalculator: exploring the evolution of mechanical stress in the CCMV capsid
- Norovirus-like VP1 particles exhibit isolate dependent stability profiles
- Compactness of viral genomes: effect of disperse and localized random mutations
- Exploring the role of genome and structural ions in preventing viral capsid collapse during dehydration
- Self consistent field theory of virus assembly
- Induced Förster resonance energy transfer by encapsulation of DNA-scaffold based probes inside a plant virus based protein cage
- Smectic viral capsids and the aneurysm instability
- Single-particle fusion of influenza viruses reveals complex interactions with target membranes
- Viral nanomechanics with a virtual atomic force microscope
- Application of Needleman-Wunch Algorithm to identify mutation in DNA sequences of Corona virus
- Molecular Study and Phylogenetic Analysis of Middle East Respiratory Syndrome Corona Virus (MERSCoV) in Camel and Human
- Functionalized magnetic microparticle-based colorimetric platform for influenza A virus detection
- Effects of inlet/outlet configurations on the electrostatic capture of airborne nanoparticles and viruses
- Inactivation of airborne viruses using a packed bed non-thermal plasma reactor
- Novel atmospheric pressure plasma device releasing atomic hydrogen: reduction of microbial-contaminants and OH radicals in the air
- Understanding cellular interactions with nanomaterials: towards a rational design of medical nanodevices
- Nano- and microparticles at fluid and biological interfaces
- Non-invasive lung disease diagnostics from exhaled microdroplets of lung fluid: perspectives and technical challenges